Published in:
01-06-2019 | Antiviral Agents | Letter
Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter]
Authors:
Jessica L. Dunne, Sarah J. Richardson, Mark A. Atkinson, Maria E. Craig, Knut Dahl-Jørgensen, Malin Flodström-Tullberg, Heikki Hyöty, Richard E. Lloyd, Noel G. Morgan, Alberto Pugliese
Published in:
Diabetologia
|
Issue 6/2019
Login to get access
Excerpt
To the Editor: We are pleased that Skog et al [
1] have accepted the challenge to respond to our recent ‘For Debate’ article [
2]. In this, we proposed that both vaccination and trials with antiviral therapies are warranted, based on decades of studies implicating an association between enterovirus infections and type 1 diabetes. It is pleasing to observe these conclusions were similarly supported by Skog et al [
1]. …